Loading...
Loading...
Among the 8 tracked institutional investors we monitor, LCTX (LINEAGE CELL THERAPEUTICS IN) is held with a combined value of $37.13M across 22,949,537 shares. The largest holder is VANGUARD GROUP INC with a position worth $16.11M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$37.13M
Total Shares Held
22,949,537
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $16.11M | 0.00% | New |
| 2 | MILLENNIUM MANAGEMENT LLC | $8.79M | 0.00% | +163.5% |
| 3 | BlackRock, Inc. | $6.11M | 0.00% | +0.8% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $3.36M | 0.01% | -11.6% |
| 5 | STATE STREET CORP | $1.72M | 0.00% | +7.3% |
| 6 | Point72 Asset Management, L.P. | $480.89K | 0.00% | +90.9% |
| 7 | FMR LLC | $305.43K | 0.00% | +0.7% |
| 8 | CITADEL ADVISORS LLC | $262.67K | 0.00% | -68.9% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LCTX with a position worth $16.11M, representing 0.00% of their portfolio. In total, 8 institutional investors hold LCTX with a combined value of $37.13M.
In the most recent quarter, 1 fund opened a new position in LCTX. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $37.13M worth of LCTX stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $16.11M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LCTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LCTX positions.